Recent developments in pathogenesis, diagnosis and therapy of Barrett's esophagus

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The burden of illness from esophageal adenocarcinoma continues to rise in the Western world, and overall prognosis is poor. Given that Barrett's esophagus (BE), a metaplastic change in the esophageal lining is a known cancer precursor, an opportunity to decrease disease development by screening and surveillance might exist. This review examines recent updates in the pathogenesis of BE and comprehensively discusses known risk factors. Diagnostic definitions and challenges are outlined, coupled with an in-depth review of management. Current challenges and potential solutions related to screening and surveillance are discussed. The effectiveness of currently available endoscopic treatment techniques, particularly with regards to recurrence following successful endotherapy and potential chemopreventative agents are also highlighted. The field of BE is rapidly evolving and improved understanding of pathophysiology, combined with emerging methods for screening and surveillance offer hope for future disease burden reduction.

Original languageEnglish (US)
Pages (from-to)6479-6490
Number of pages12
JournalWorld Journal of Gastroenterology
Volume21
Issue number21
DOIs
StatePublished - Jun 7 2015

Fingerprint

Barrett Esophagus
Western World
Cost of Illness
Adenocarcinoma
Therapeutics
Recurrence
Neoplasms

Keywords

  • Barrett's esophagus
  • Esophageal cancer
  • Esophagus
  • Gastroesophageal reflux disease

ASJC Scopus subject areas

  • Gastroenterology

Cite this

@article{0b7b6d7238e44df99109fcbd103b881a,
title = "Recent developments in pathogenesis, diagnosis and therapy of Barrett's esophagus",
abstract = "The burden of illness from esophageal adenocarcinoma continues to rise in the Western world, and overall prognosis is poor. Given that Barrett's esophagus (BE), a metaplastic change in the esophageal lining is a known cancer precursor, an opportunity to decrease disease development by screening and surveillance might exist. This review examines recent updates in the pathogenesis of BE and comprehensively discusses known risk factors. Diagnostic definitions and challenges are outlined, coupled with an in-depth review of management. Current challenges and potential solutions related to screening and surveillance are discussed. The effectiveness of currently available endoscopic treatment techniques, particularly with regards to recurrence following successful endotherapy and potential chemopreventative agents are also highlighted. The field of BE is rapidly evolving and improved understanding of pathophysiology, combined with emerging methods for screening and surveillance offer hope for future disease burden reduction.",
keywords = "Barrett's esophagus, Esophageal cancer, Esophagus, Gastroesophageal reflux disease",
author = "Magnus Halland and Katzka, {David A} and Iyer, {Prasad G}",
year = "2015",
month = "6",
day = "7",
doi = "10.3748/wjg.v21.i21.6479",
language = "English (US)",
volume = "21",
pages = "6479--6490",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "21",

}

TY - JOUR

T1 - Recent developments in pathogenesis, diagnosis and therapy of Barrett's esophagus

AU - Halland, Magnus

AU - Katzka, David A

AU - Iyer, Prasad G

PY - 2015/6/7

Y1 - 2015/6/7

N2 - The burden of illness from esophageal adenocarcinoma continues to rise in the Western world, and overall prognosis is poor. Given that Barrett's esophagus (BE), a metaplastic change in the esophageal lining is a known cancer precursor, an opportunity to decrease disease development by screening and surveillance might exist. This review examines recent updates in the pathogenesis of BE and comprehensively discusses known risk factors. Diagnostic definitions and challenges are outlined, coupled with an in-depth review of management. Current challenges and potential solutions related to screening and surveillance are discussed. The effectiveness of currently available endoscopic treatment techniques, particularly with regards to recurrence following successful endotherapy and potential chemopreventative agents are also highlighted. The field of BE is rapidly evolving and improved understanding of pathophysiology, combined with emerging methods for screening and surveillance offer hope for future disease burden reduction.

AB - The burden of illness from esophageal adenocarcinoma continues to rise in the Western world, and overall prognosis is poor. Given that Barrett's esophagus (BE), a metaplastic change in the esophageal lining is a known cancer precursor, an opportunity to decrease disease development by screening and surveillance might exist. This review examines recent updates in the pathogenesis of BE and comprehensively discusses known risk factors. Diagnostic definitions and challenges are outlined, coupled with an in-depth review of management. Current challenges and potential solutions related to screening and surveillance are discussed. The effectiveness of currently available endoscopic treatment techniques, particularly with regards to recurrence following successful endotherapy and potential chemopreventative agents are also highlighted. The field of BE is rapidly evolving and improved understanding of pathophysiology, combined with emerging methods for screening and surveillance offer hope for future disease burden reduction.

KW - Barrett's esophagus

KW - Esophageal cancer

KW - Esophagus

KW - Gastroesophageal reflux disease

UR - http://www.scopus.com/inward/record.url?scp=84930816172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930816172&partnerID=8YFLogxK

U2 - 10.3748/wjg.v21.i21.6479

DO - 10.3748/wjg.v21.i21.6479

M3 - Article

C2 - 26074687

AN - SCOPUS:84930816172

VL - 21

SP - 6479

EP - 6490

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 21

ER -